Authors
Latest:
Unmet Needs and Future Directions in Risk Assessment For Prostate CancerDr Andriole shares remaining unmet needs in prostate cancer risk assessment and shares his hopes for the future.
Latest:
Treatment intensification in advanced prostate cancer: Real-world practice lags behind data"It gives me a very rewarding experience…. I see patients with low-grade prostate cancer and when they become advanced prostate cancer, I already have a good relationship with them and don’t have to send them somewhere else," says Abhinav Sidana, MD, MPH.
Latest:
Test could help detect bladder cancer recurrenceAn easy-to-administer urine test looking for telomerase reverse transcriptase mutations helps detect recurring urothelial bladder cancer, especially non-muscle-invasive bladder cancer, early on, according to a new study.
Latest:
How to use urodynamics to assess voiding dysfunctionUrodynamic tests should be tailored to an individual patient's suspected dysfunction
Latest:
Ureteroscopy: Surgeons show techniques, tips in videosIn these videos, high-volume stone surgeons demonstrate novel approaches to classification, visualization, and treatment of stones.
Latest:
Subspecialization trends: Who’s doing what and where?In this interview, Michael Palese, MD, discusses subspecialization, its benefits for clinicians and patients, and what the future “office urologist” may look like.
Latest:
Robotic urologic surgery shows benefits for both physician, patientWhile cost remains a concern, incorporating robotics into urologic laparoscopy appears to improve the experience for patients and physicians alike.
Latest:
Beta-3 agonist significantly reduces urge incontinenceThe oral beta-3 agonist vibegron, taken once daily at either 50 mg or 100 mg, is well tolerated and results in clinically and statistically significant reductions in daily micturitions, urge incontinence, and urgency episodes.
Latest:
Despite data, cautery-free RAP approach preferredCleveland-Although their data show otherwise, a group of researchers at the University of Rochester (NY) Medical Center have faith that using a cautery-free approach with Weck clips to preserve the neurovascular bundle during robot-assisted prostatectomy is a better choice than bipolar cautery.
Latest:
Metallic stents efficacious for malignant ureteral obstructionA new study suggests that metallic Resonance ureteral stents are a good option for management of malignant ureteral obstruction because they promote strong long-term outcomes.
Latest:
How information blocking updates may affect your practice"Urologists may wish to review their policies for patient portal, responding to requests for records, and supporting the concept of a shared electronic record," writes Robert A. Dowling, MD.
Latest:
Treatment of metastatic renal cell carcinoma: What can we offer?To optimize outcomes for patients with advanced renal cell carcinoma, multimodal therapy is often required.
Latest:
Treatment of metastatic renal cell carcinoma: What can we offer?To optimize outcomes for patients with advanced renal cell carcinoma, multimodal therapy is often required.
Latest:
No business as usual post COVID? Maybe a good thing"Professionally, I am mentally and logistically preparing for a different medical environment when we all return from isolation. I doubt it will ever be business as usual again," writes Bradley A. Erickson, MD, MS.
Latest:
Stones, stents, sepsis, and the need for some common sense"If we can’t get the emergency rooms physicians to apply a bit of common sense to medicine, maybe we should require that they all have a ureteral stent placed for a few weeks during their residency so that they have a better idea of what these patients go through," writes Henry Rosevear, MD.
Latest:
Letter: IMRT ownership study methodology unsound"Utilization analysis of health care resources must be free of bias, methodologically sound, and relevant to current practice," writes Deepak A. Kapoor, MD.
Latest:
How to prevent stone formation in patients with metabolic syndromeThis article examines the relationship between the metabolic syndrome and kidney stone disease. We explain elements of the metabolic workup and practical strategies for prevention and management of stones in patients with the metabolic syndrome.
Latest:
Best of AUA 2015: PCa surveillance, surgical controversies create buzzUrology Times’ “Best of AUA 2015” report provides a guide to the meeting’s take-home messages in 15 therapeutic areas-an information-packed, condensed summary of the top papers and presentations.
Latest:
Software systems begin to merge business, medical dataAn important trend is emerging in the arena of practice management systems,and industry observers say urologists would be well advised to keep up todate on it.
Latest:
Mirabegron may improve erectile dysfunction in men with overactive bladder symptomsThe findings support continued investigation of the safety and efficacy of mirabegron in men with OAB and concurrent ED, says study author Arthur L. Burnett, II, MD, MBA.
Latest:
Immunotherapy for bladder Ca: What urologists need to knowPeter Black, MD, discusses which patients are currently eligible for immunotherapy, how the indications are likely to expand, some of the common side effects of immunotherapy and their incidence, and the availability of tools to determine which patients are suitable candidates for treatment.
Latest:
Nocturia: An update on diagnosis and treatmentIn this video, Alan J. Wein, MD, PhD, discusses recent developments in the management of nocturia, including a new FDA-approved agent; underlying causes; and the role of a voiding diary in patient care.
Latest:
Tips for integrating APPs into your practiceAnne E. Calvaresi, DNP, CRNP, RNFA, also discusses best practices that urologists and APPs can follow to ensure they work together well as a team and offers her opinion on the controversy surrounding the use of APPs for performing certain urologic procedures.
Latest:
Unmet Needs Surrounding the Treatment of Prostate CancerPaul M. Yonover, MD, FACS, offers closing thoughts on unmet needs and clinical challenges surrounding the treatment of prostate cancer.
Latest:
Hydrogel spacer use during prostate RT: Community experienceRecent data support the product’s use in protecting organs at risk for radiation exposure.
Latest:
From prep to follow-up: Key considerations for administering onabotulinumtoxinABenjamin M. Brucker, MD, discusses best practices for the onabotulinumtoxinA procedure, spanning all phases of treatment—before, during, and after administration.
Latest:
Laser vaginal rejuvenation: What urologists need to know"The world of laser vaginal rejuvenation is fast paced, with new companies adding a laser platform nearly each month," write Jessica DeLong, MD, and Jennifer Miles-Thomas, MD.
Latest:
Depression and suicide in men: Identifying the riskThis article discusses the risk of depression and suicide in men, focusing on increased risk in men with genitourinary cancer and other urologic conditions.
Latest:
Should your practice consider a MIPS virtual group?“Urology practices that are struggling to achieve payment increases and bonuses under MIPS for 2017 and 2018 may reap some strategic benefits from taking the lead in forming virtual groups in subsequent years,” according to Rick Rutherford, CMPE.
Latest:
A Look Into The Future of PSMA-Targeted Therapies in Prostate CancerPanelists review the recent FDA approval of the PSMA-targeted therapy Lutetium Lu 177 vipivotide tetraxetan for patients with metastatic castration-resistant prostate cancer and discuss additional settings in which it, and other PSMA-targeted treatments, might be used in the future.
